AllianceRx Walgreens Prime Studies Adherence in Cystic Fibrosis, Ulcerative Colitis/Crohn ' s Disease Patients

ORLANDO, Fla., June 1, 2022. AllianceRx Walgreens Prime and Walgreens recently announced results from separate research studies exploring the impact of adherence on hospitalizations and medical costs as they related to cystic fibrosis (CF) and...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials